Skip to main content

Advertisement

Log in

Aggressive Fibromatose (Desmoidfibromatose)

Seltene Differentialdiagnose einer Nierenzellkarzinommetastase

Aggressive fibromatosis (desmoid tumor)

A rare differential diagnosis of metastasis of renal cell carcinoma

  • Kasuistiken
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Falldarstellung einer 65-jährigen Patientin mit aggressiver Fibromatose des M. rectus abdominis bei initialer Verdachtsdiagnose einer Nierenzellkarzinommetastase nach zurückliegender Tumornephrektomie. Die aggressive Fibromatose (syn. Desmoidfibromatose) ist eine seltene semimaligne Tumorentität des Bindegewebes mit lokal-infiltrativem, destruierendem Wachstum. Sie muss als seltene Differentialdiagnose einer NZK-Metastase angesehen werden. Zur Vermeidung eines Rezidivs ist die R0-Resektion mit anschließender adjuvanter Radiatio anzustreben.

Abstract

We report the case of a 65-year-old woman with an aggressive fibromatosis of the rectus abdominis muscle suspicious for a metastasis of renal cell carcinoma after tumor nephrectomy 3 years previously. Aggressive fibromatoses (desmoid tumors) are rare semimalignant tumors of the connective tissue with local infiltration and destruction of tissue. Complete resection is essential to avoid tumor relapse. Aggressive fibromatosis must be considered in the differential diagnosis of renal cell carcinoma metastasis. Complete resection and subsequent radiotherapy seem to be the therapy of choice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Altmann S, Lenz-Scharf O, Schneider W (2008) Therapieoptionen bei der aggressiven Fibromatose. Handchir Mikrochir Plast Chir 40:88–93

    Article  CAS  PubMed  Google Scholar 

  2. Ballo MT, Zagars GK, Pollack A et al (1999) Desmoid Tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17(1):158–167

    CAS  PubMed  Google Scholar 

  3. Domenech A, Rodriguez-Gasen A, Benitez A et al (2008) Metastasis of clear cell renal carcinoma in skeletal muscle. Rev Esp Med Nucl 27(6):442–443

    Article  CAS  PubMed  Google Scholar 

  4. Fimmanò A, Coppola BE, Cirillo C et al (2006) Desmoid tumor of the chest wall foiling surgery. Ann Ital Chir 77(2):169–172

    PubMed  Google Scholar 

  5. Fröhlich N, Emmrich P, Vitzthum HE (2005) Formation of desmoids in postoperative lumbar scars – a case report. Z Orthop Ihre Grenzgeb 143(1):117–119

    Article  PubMed  Google Scholar 

  6. Fujita K, Sugao H, Tsujikawa K, Itoh Y (2003) Desmoid tumor in a scar from radical nephrectomy for renal cancer. Int J Urol 10:274–275

    Article  PubMed  Google Scholar 

  7. Ghysel C, Joniau S, van Poppel H (2006) The role of metastasectomy in renal cell carcinoma. Eur Urol 5(Suppl):221

    Google Scholar 

  8. Ioannou M, Demertzis N, Iakovidou I, Kottakis S (2007) The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors. Anticancer Res 27(2):1143–1147

    CAS  PubMed  Google Scholar 

  9. Kolokythas O, Beulig HU, Schulte M, Merkle E (1996) Radiologisch-pathologische Konferenz: Aggressive Fibromatose, Röntgenpraxis 49:279–280

  10. Kuhnen C, Helwing M, Rabstein S et al (2005) Desmoidfibromatosen (aggressive Fibromatosen). Pathologe 26:117–126

    Article  CAS  PubMed  Google Scholar 

  11. Lazar AJ, Tuvin D, Hajibashi S et al (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoids tumors. Am J Pathol 173(5):1518–1527

    Article  CAS  PubMed  Google Scholar 

  12. Meimarakis M, Winter H, Hoffmann G, Zilbauer A et al (2007) Langzeitergebnisse und Prognosefaktoren nach Resektion pulmonaler Metastasen beim Nierenzellkarzinom. Meeting-Abstract, 124. Kongress der Deutschen Gesellschaft für Chirurgie, München

  13. Reitamo JJ, Hayry P, Nykyri E, Saxen E (1982) The desmoid tumor. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673

    CAS  PubMed  Google Scholar 

  14. Russo P, O’Brien MF (2008) Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy. Urol Clin North Am 35(4):679–686

    Article  PubMed  Google Scholar 

  15. Skubitz KM, Manivel JC, Clohisy DR, Frolich JW (2009) Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors. Cancer Chemother Pharmacol 64(3):635–640

    Article  CAS  PubMed  Google Scholar 

  16. Staehler M, Kruse J, Haseke N et al (2008) Effect of metastasectomy on survival in patients with metastatic renal cell cancer: 10 year experience in 240 patients. J Clin Oncol 26:5107

    Article  Google Scholar 

  17. Thomas AA, Rini BI, Campbell SC (2009) Integration of surgery and systemic therapy in the management of metastatic renal cancer. Curr Urol Rep 10(1):35–41

    Article  PubMed  Google Scholar 

  18. Tolan S, Shanks JH, Loh MY et al (2007) Fibromatosis: benign by name but not necessarily by nature. Clin Oncol (R Coll Radiol) 19(5):319–326

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Janitzky.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janitzky, A., Porsch, M., Daher, M. et al. Aggressive Fibromatose (Desmoidfibromatose). Urologe 49, 81–83 (2010). https://doi.org/10.1007/s00120-009-2135-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-009-2135-9

Schlüsselwörter

Keywords

Navigation